Miclast (Ciclopirox Olamine)

Ciclopirox olamine, the active ingredient in Miclast, chelates metal ions that are essential for fungal enzyme activity. By inhibiting metal‑dependent enzymes, it disrupts membrane transport, protein synthesis, and energy production within fungal cells, leading to cell death and clearance of the infection.

The dosage of Miclast is determined by the prescribing healthcare professional based on the specific indication, severity of infection, patient age, and treatment area. The prescriber will provide instructions on the amount to apply, frequency, and duration of therapy.

Safety data for ciclopirox olamine in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks before prescribing Miclast to pregnant or breastfeeding individuals. Use only if clearly needed and directed by a qualified professional.

To request Miclast, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Miclast (ciclopirox olamine) offers a broad spectrum of activity against dermatophytes, yeasts, and some molds, and is applied topically, avoiding systemic exposure. Compared with azole creams, ciclopirox has a distinct mechanism that may be useful when resistance to azoles is suspected, though clinical choice depends on infection type and physician judgment.

Miclast should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use to maintain stability.

Miclast is applied topically to the affected skin or nail area. The prescriber will advise the amount to use, typically a thin layer, and the frequency (often once or twice daily). Hands should be washed before and after application, and the treated area should be clean and dry.

While generally well tolerated, Miclast can cause severe skin reactions such as allergic contact dermatitis, urticaria, blistering, facial or lip swelling (angioedema), and rare systemic hypersensitivity. Patients should discontinue use and seek medical attention if any of these serious symptoms develop.

Miclast should not be used on patients with known hypersensitivity to ciclopirox olamine or any of the formulation excipients. It is also contraindicated on extensive broken skin, mucous membranes, or in individuals where a systemic antifungal is required without medical supervision.